Santosh Vetticaden Insider Trading $INSY Insys Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Santosh Vetticaden.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Santosh Vetticaden. Santosh Vetticaden is SVP, Chief Medical Officer *** in DEPOMED INC ($DMI) and Chief Medical Officer in MAXYGEN INC ($MAXY) and Senior Vice President in MAXYGEN INC ($MAXY) and Interim CEO in Insys Therapeutics, Inc. ($INSY) and Interim CEO and CMO in Insys Therapeutics, Inc. ($INSY).

Santosh Vetticaden in Insys Therapeutics, Inc.

Trading Symbol: INSY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Santosh Vetticaden: Interim CEO and CMO, Interim CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2017
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Santosh Vetticaden in Insys Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DMI, INSY, MAXY

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Feb 23 2017	INSY	Insys Therapeutics ...	Vetticaden Santosh	Interim CEO and CMO	Option Exercise	A	0.00	14,000	0	14,000
Feb 23 2017	INSY	Insys Therapeutics ...	Vetticaden Santosh	Interim CEO and CMO	Option Exercise	A	12.65	56,000	708,400	56,000
Jan 17 2017	INSY	Insys Therapeutics ...	Vetticaden Santosh	Interim CEO	Option Exercise	A	10.39	30,000	311,700	30,000

Page: 1